KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Enterprise Value Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -2.64%
Dec 31, 2025 3.03%
Sep 30, 2025 5.24%
Jun 30, 2025 6.81%
Mar 31, 2025 -1.92%
Dec 31, 2024 -6.09%
Sep 30, 2024 15.45%
Jun 30, 2024 15.63%
Mar 31, 2024 18.07%
Dec 31, 2023 17.88%
Sep 30, 2023 -3.03%
Jun 30, 2023 -3.10%
Mar 31, 2023 0.38%
Dec 31, 2022 25.91%
Sep 30, 2022 22.61%
Jun 30, 2022 28.79%
Mar 31, 2022 29.80%
Dec 31, 2021 26.74%
Sep 30, 2021 19.40%
Jun 30, 2021 25.42%
Mar 31, 2021 21.18%
Dec 31, 2020 19.44%
Sep 30, 2020 16.86%
Jun 30, 2020 17.56%
Mar 31, 2020 21.64%
Dec 31, 2019 19.90%
Sep 30, 2019 5.77%
Jun 30, 2019 3.64%
Mar 31, 2019 -5.84%
Dec 31, 2018 -8.60%
Sep 30, 2018 -21.80%
Jun 30, 2018 -5.95%
Mar 31, 2018 -8.63%
Dec 31, 2017 -11.61%
Sep 30, 2017 -10.26%
Jun 30, 2017 -46.32%
Mar 31, 2017 -55.62%
Dec 31, 2016 -13.03%
Sep 30, 2016 -11.17%
Jun 30, 2016 -21.55%
Mar 31, 2016 -36.98%
Dec 31, 2015 -11.90%
Sep 30, 2015 -21.78%
Jun 30, 2015 -31.57%
Mar 31, 2015 -37.96%
Dec 31, 2014 -12.05%
Sep 30, 2014 -14.18%
Jun 30, 2014 -20.17%
Mar 31, 2014 -48.12%